Short answer
FENNEC PHARMACEUTICALS INC. (FENC) filed an 8-K current report with the SEC on May 22, 2026 reporting Item 8.01 (Other Events). New PEDMARK research to be presented at ASCO 2026.
FENNEC PHARMACEUTICALS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- New PEDMARK research to be presented at ASCO 2026
- Data spans multiple patient populations and tumor types
- Potential evidence expansion for PEDMARK’s clinical and commercial positioning
- Full study details available in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FENNEC PHARMACEUTICALS INC. 8-K filings
Get the next FENC 8-K as it lands
Follow FENC for push alerts, or ask the research agent what this filing means.